State insurance office presents five options to tackle health care costs; transparency and drug boards outline next steps

The Senate Health & Long Term Care Committee heard a work session Jan. 23 on state efforts to address health care affordability, including a detailed Office of the Insurance Commissioner (OIC) report and updates from the Healthcare Cost Transparency Board, the Prescription Drug Affordability Board and the Universal Health Care Commission.

The OIC presentation, led by Nico Janssen, senior health policy analyst, and Jane Beyer, senior health policy advisor, summarized a legislative-directed report that used Washington-specific data to model five policy options aimed at lowering prices and premiums. Janssen told the committee that “we published this report in August of last year” and framed the analysis around Washington’s payer mix.

Why it matters: The report models interventions that affect different parts of the state health system—individual and small-group markets, insurers and hospitals—and provides numeric estimates Washington policymakers can use when weighing tradeoffs between consumer savings and state or provider costs.

Major findings and options analyzed

- Reinsurance: The OIC modeled a reinsurance program designed to reduce premiums by about 10% in affected markets but cautioned that the program could carry substantial annual state costs — the presentation estimated up to $84,000,000 for the individual market and up to $294,000,000 for the small-group market, depending on design and funding sources.

- Medical loss ratio (MLR): Under federal law insurers must spend a minimum share of premiums on…